References
- Jensen N. H., Dragsted L., Christensen J. K., Jorgensen J. C., Qvist J. Severity of illness and outcome in alcoholic patients in the intensive care unit. Intensive Care Med 1988; 15: 19–22
- Tonnesen H., Petersen K. R., Hojgaard L., et al. Postoperative morbidity among symptom‐free alcoholic misusers. Lancet 1992; 340: 334–337
- Moore R. D., Bone L. R., Geller G., Mamon J. A., Stokes E. J., Levine D. M. Prevalence, detection, and treatment of alcoholism in hospitalized patients. JAMA 1989; 261: 403–407
- Wrobel N., Thalhofer S., Koppel C. Clonidine in alcohol withdrawal delirium in ICU patients. Intensivther Notfallmed 1991; 16: 113–116
- Deutsche Hauptstelle gegen die Suchtgefahren (DHS). Jahrbuch Sucht'92 1993; 1–16, Geesthacht
- Mihas A. A., Tavassoli M. Laboratory markers of ethanol intake and abuse: a critical appraisal. Am J Med Sci 1992; 303: 415–428
- Crabb D. W. Biological markers for increased risk of alcoholism and for quantitation of alcohol consumption. J Clin Invest 1990; 85: 311–315
- Korri U. M., Nuutinen H., Salaspuro M. Increased blood acetate: a new laboratory marker of alcoholism and heavy drinking. Alcohol Clin Exp Res 1985; 9: 468–471
- Homaidan F. R., Kricka L. J., Bailey A. R., Whitehead T. P. Red cell morphology in alcoholics: a new test for alcohol abuse. Blood Cells 1986; 11: 375–392
- Rommelspacher H., Damm H., Schmidt L., Schmidt G. Increased excretion of harman by alcoholics depends on events of their life history and the state of the liver. Psychopharmacology 1985; 87: 64–68
- Rommelspacher H., Biichau C., Weiss J. Harman induces preference for ethanol in rats: is the effect specific for ethanol?. Pharmacol Biochem Behav 1987; 26: 749–755
- Rommelspacher H., Schmidt L. G., May T. Plasma norharman (β‐carboline) levels are elevated in chronic alcoholics. Alcohol Oin Exp Res 1991; 15: 553–559
- Nilssen O., Huseby N. E., Hoyer G., Brenn T., Schirmer H., Forde O. H. New alcohol markers. How useful are they in population studies: the Svalbard Study 1988‐89. Alcohol Clin Exp Res 1992; 16: 82–86
- Stibler H. Carbohydrate‐deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 1991; 37: 2029–2037
- Kwoh‐Gain I., Fletcher L. M., Price J., Powell L. W., Halliday J. W. Desialyted transferrin and mitochondrial aspartate aminotransferase compared as laboratory markers of excessive alcohol consumption. Clin Chem 1990; 36: 841–845
- Allen J. P., Litten R. Z., Anton R. F., Cross G. M. Carbohydrate‐deficient transferrin as a measure of immoderate drinking: remaining issues. Alcohol Clin Exp Res 1994; 18: 799–812
- Fagerberg B., Agewall S., Berglund A., Wysocki M., Lundberg P. A., Lindstedt G. Is carbohydrate‐deficient transferrin in serum useful for detecting excessive alcohol consumption in hypertensive patients?. Clin Chem 1994; 40: 2057–2063
- Bisson J. I., Milford‐Ward A. A comparison of carbohydrate deficient transferrin with other markers of alcohol misuse in male soldiers under the age of thirty. Alcohol Alcohol 1994; 29: 315–321
- Anton R. F., Moak D. H. Carbohydrate‐deficient transferrin and gamma‐glutamyltransferaseas markers of heavy alcohol consumption: gender differences. Alcohol Oin Exp Res 1994; 18: 747–754
- Müller Ch., Moritz R., Bräutigam K. Vereinfachte Methode zur Bestimmung des desialysierten Transferrins im Serum. Lab Med 1991; 15: 278
- Buchsbaum D. G., Buchanan R. G., Centor R. M., Schnoll S. H., Lawton M. J. Screening for alcohol abuse using CAGE score's and likelihood ratios. Ann Intern Med 1991; 115: 774–777
- Ewing J. A. Detecting alcoholism. The CAGE questionnaire. JAMA 1984; 252: 1905–1907
- Shaw J. M., Kolesar G. S., Sellers E. M., Kaplan H. L., Sandor P. Development of optimal treatment tactics for alcohol withdrawal. I. Assessment and effectiveness of supportive care. J Clin Psychopharmacol 1981; 1: 382–387